Your search

Filter the results

By type of result

By number of elements

17 results

Team 2 - Helicobacter infection: Inflammation and Cancer (31 October 2018)

cardia gastric cancers and is the third cause of mortality by cancer in the world with nearly 1 million new cases per year. H. pylori infection consistently induces a chronic inflammation of the gastric ... Team 2 research is dedicated to the study of the pathogenicity of Helicobacter, in particular in the context of digestive cancers associated to Helicobacter infection: Helicobacter pylori infection ... Team 2 - Helicobacter infection: Inflammation and Cancer

Team 1 - Liver Cancer and Tumor Invasion (25 June 2018)

Hepatocellular carcinoma (HCC) is the major type of primary liver cancer. It is the 6th most frequent cancer worldwide and the 2nd leading cause of cancer-related death. The overall poor prognosis of HCC is due ... Team 1 - Liver Cancer and Tumor Invasion

30th International Workshop on Helicobacter & Microbiota in Inflammation & Cancer (29 August 2017)

XXXth International Workshop on Helicobacter & Microbiota in Inflammation & Cancer will be held in Bordeaux, France on September 7-9, 2017. ... 30th International Workshop on Helicobacter & Microbiota in Inflammation & Cancer

Organization of the Unit (23 January 2018)

The BaRITOn unit is composed of three INSERM teams. Team 1 - Liver cancer and tumor invasion Team 2 - Helicobacter infection: Inflammation and Cancer Team 3 - Oncogenesis of cutaneous ... Cancer, invasion, liver cancer, actin cytoskeleton, invadosomes, metastases, gastric cancer, gastric MALT lymphoma, cancer stem cells, toxins, Helicobacter pylori, Cutaneous lymphomas, telomerase

Presentation of the unit (22 May 2017)

Cancer, invasion, liver cancer, actin cytoskeleton, invadosomes, small GTPases, metastases, Rho GTPases, collagen, DDR, gastric cancer, gastric MALT lymphoma, cancer stem cells, toxins

Two awards from La Ligue Gironde for BaRITOn Unit (25 June 2018)

Christine Varon (Team 2) and Violaine Moreau (Team 1) received a grant from the Ligue contre le cancer (Gironde).

Group M. Bouchecareilh (07 February 2018)

involvement in Liver cancer progression   News Marion will present her data at the 6th Alpha-1 Global Patient Congress: Lisbon, Portugal / 5-8 April, 2017. Marion’s interview for Alpha 1 Global.   People ... Our research focuses on the identification of biomarkers and new therapeutic targets involved in liver physiopathology (Rare disease: Alpha 1-Antitrypsin Deficiency and Cancer: Hepatocellular

Team 1 awarded FRM label 2018 (05 September 2018)

The "Liver Cancer and Tumor Invasion" team from BaRITOn led by Violaine Moreau and Frédéric Saltel, has just been awarded the "FRM Team of the Fondation de la Recherche Médicale" label.

The word from the Director (10 April 2017)

by a common interest in human translational research. Each team or section has a longstanding experience in its own domain but shares with the others a common interest in cancer cell biology and a willingness

The word from the Director (14 October 2017)

by a common interest in human translational research. Each team or section has a longstanding experience in its own domain but shares with the others a common interest in cancer cell biology and a willingness